HMGB1 and cervical carcinoma: In contrast, we found that the HMGB1 rs2249825 polymorphic variants showed no significant association with prostate cancer susceptibility (Table 2) or the clinical status of prostate cancer, suggesting a difference from colorectal cancer [33] and cervical cancer [47].